Lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19

Coronavirus disease 2019 (COVID-19), caused by SARS coronavirus 2 (SARS-CoV-2), is spreading rapidly with no established effective treatments.

Bioseutica statement on the COVID-19 outbreak

Zeewolde, March 28, 2020

The COVID-19 pandemic worries us all.

Bioseutica® co-founds Healiva®

We are excited to announce Healiva SA, an innovative startup venture in Lugano, Switzerland co-founded by Bioseutica BV.

Health Canada GMP inspection
In August 2018 Neova Technologies Inc. (NTI), a Bioseutica Group company had an inspection by Health Canada and received a compliance rating indicating that the activities inspected met the requirements outlined in the Canadian Food & Drug Act and its associated regulations.
Raising the bar of quality excellence

Our food production plant in Zeewolde (NL) has been inspected by FDA in October 2019, in accordance with “Preventive Controls and  Sanitary Human Food Operations-7303.040 Domestic and Imported Nutr